Literature DB >> 2991107

Acute and chronic changes in the microcirculation of the liver in inbred strains of mice following infection with mouse hepatitis virus type 3.

P J MacPhee, V J Dindzans, L S Fung, G A Levy.   

Abstract

The acute and chronic effects of mouse hepatitis virus type 3 on the microcirculation of the liver in both semisusceptible C3HeB/FeJ and fully resistant A/J mice were studied. In the C3HeB/FeJ mice, abnormalities of microcirculatory flow were noted as early as 12 hr after infection and by 24 hr, localized avascular foci appeared. Disturbances were characterized by granular blood flow, sinusoidal microthrombi, distortion of sinusoids by edematous hepatocytes and necrotic lesions. Following the acute infection, Day 10, two patterns of chronic disease were observed. Eighty percent of the mice developed chronic granulomatous hepatitis whereas in the remaining 20% a more severe chronic aggressive hepatitis was observed which was characterized by ongoing hepatocellular necrosis and a marked mononuclear cell infiltrate. In both cases, in vivo microcirculatory abnormalities were found predominantly around visible lesions. Onset of the microcirculatory abnormalities was found to be concomitant with a rise in monocyte related procoagulant activity. Procoagulant activity rose acutely and remained elevated throughout the chronic phase but was higher in animals with severe disease. In contrast to the above, normal blood flow and histology were seen in the resistant A/J mice at all times following infection, and procoagulant activity remained at basal levels despite active viral replication as demonstrated by immunofluorescence studies and recovery of infectious virus. These observations suggest a role for monocyte procoagulant activity in the development of microcirculatory abnormalities following mouse hepatitis virus type 3 infection which may be important in the pathogenesis of the disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2991107      PMCID: PMC7165583          DOI: 10.1002/hep.1840050422

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  29 in total

Review 1.  ASPECTS OF THE PATHOGENESIS OF VIRUS DISEASES.

Authors:  C A MIMS
Journal:  Bacteriol Rev       Date:  1964-03

2.  The microcirculatory acinar concept of normal and pathological hepatic structure.

Authors:  A M Rappaport
Journal:  Beitr Pathol       Date:  1976-05

3.  The immune response to mouse hepatitis virus: expression of monocyte procoagulant activity and plasminogen activator during infection in vivo.

Authors:  V J Dindzans; P J MacPhee; L S Fung; J L Leibowitz; G A Levy
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

4.  Electron microscopy of the hepatocellular and Kupffer-cell lesions of mouse hepatitis, with particular reference to the effect of cortisone.

Authors:  B H Ruebner; T Hirano; R J Slusser
Journal:  Am J Pathol       Date:  1967-08       Impact factor: 4.307

Review 5.  The virology and immunobiology of lymphocytic choriomeningitis virus infection.

Authors:  M J Buchmeier; R M Welsh; F J Dutko; M B Oldstone
Journal:  Adv Immunol       Date:  1980       Impact factor: 3.543

6.  Activation of natural killer cells and induction of interferon after injection of mouse hepatitis virus type 3 in mice.

Authors:  L Schindler; H Engler; H Kirchner
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

7.  The pathobiology of viral hepatitis and immunologic activation of the coagulation protease network.

Authors:  G A Levy; H Helin; T S Edgington
Journal:  Semin Liver Dis       Date:  1984-02       Impact factor: 6.115

Review 8.  Relationships among the complement, kinin, coagulation and fibrinolytic systems in the inflammatory reaction.

Authors:  J S Sundsmo; D S Fair
Journal:  Clin Physiol Biochem       Date:  1983

Review 9.  Functional implications of liver cell heterogeneity.

Authors:  J J Gumucio; D L Miller
Journal:  Gastroenterology       Date:  1981-02       Impact factor: 22.682

10.  The effect of mouse hepatitis virus infection on the microcirculation of the liver.

Authors:  G A Levy; P J MacPhee; L S Fung; M M Fisher; A M Rappaport
Journal:  Hepatology       Date:  1983 Nov-Dec       Impact factor: 17.425

View more
  24 in total

1.  Clinical significance of hepatic derangement in severe acute respiratory syndrome.

Authors:  Henry-Lik-Yuen Chan; Ambrose-Chi-Pong Kwan; Ka-Fai To; Sik-To Lai; Paul Kay-Sheung Chan; Wai-Keung Leung; Nelson Lee; Alan Wu; Joseph Jao-Yiu Sung
Journal:  World J Gastroenterol       Date:  2005-04-14       Impact factor: 5.742

Review 2.  The Duality of Fgl2 - Secreted Immune Checkpoint Regulator Versus Membrane-Associated Procoagulant: Therapeutic Potential and Implications.

Authors:  Jiemiao Hu; Jun Yan; Ganesh Rao; Khatri Latha; Willem W Overwijk; Amy B Heimberger; Shulin Li
Journal:  Int Rev Immunol       Date:  2014-09-26       Impact factor: 5.311

3.  Mechanisms for virus-induced liver disease: tumor necrosis factor-mediated pathology independent of natural killer and T cells during murine cytomegalovirus infection.

Authors:  J S Orange; T P Salazar-Mather; S M Opal; C A Biron
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

4.  Fulminant hepatic failure in murine hepatitis virus strain 3 infection: tissue-specific expression of a novel fgl2 prothrombinase.

Authors:  J W Ding; Q Ning; M F Liu; A Lai; J Leibowitz; K M Peltekian; E H Cole; L S Fung; C Holloway; P A Marsden; H Yeger; M J Phillips; G A Levy
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

Review 5.  Fulminant hepatitis.

Authors:  S Sinclair; A Wakefield; G Levy
Journal:  Springer Semin Immunopathol       Date:  1990

6.  Loss of resistance to murine hepatitis virus strain 3 infection after treatment with corticosteroids is associated with induction of macrophage procoagulant activity.

Authors:  R J Fingerote; M Abecassis; M J Phillips; Y S Rao; E H Cole; J Leibowitz; G A Levy
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

7.  16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection.

Authors:  M Abecassis; J A Falk; L Makowka; V J Dindzans; R E Falk; G A Levy
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

8.  The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis.

Authors:  Philip A Marsden; Qin Ning; Laisum S Fung; Xioping Luo; Yue Chen; Michael Mendicino; Anand Ghanekar; Jeremy A Scott; Teresa Miller; Camie W Y Chan; Mathew W C Chan; Wei He; Reginald M Gorczynski; David R Grant; David A Clark; M James Phillips; Gary A Levy
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

9.  Association of mouse fibrinogen-like protein with murine hepatitis virus-induced prothrombinase activity.

Authors:  R L Parr; L Fung; J Reneker; N Myers-Mason; J L Leibowitz; G Levy
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

10.  Pattern of disease after murine hepatitis virus strain 3 infection correlates with macrophage activation and not viral replication.

Authors:  M Pope; O Rotstein; E Cole; S Sinclair; R Parr; B Cruz; R Fingerote; S Chung; R Gorczynski; L Fung
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.